193 related articles for article (PubMed ID: 26582563)
21. Microemulsion based gel for topical dermal delivery of pseudolaric acid B: In vitro and in vivo evaluation.
Wan T; Xu T; Pan J; Qin M; Pan W; Zhang G; Wu Z; Wu C; Xu Y
Int J Pharm; 2015 Sep; 493(1-2):111-20. PubMed ID: 26216411
[TBL] [Abstract][Full Text] [Related]
22. Nanocrystal-based gel of apremilast ameliorates imiquimod-induced psoriasis by suppressing inflammatory responses.
Parmar PK; Sharma N; Wasil Kabeer S; Rohit A; Bansal AK
Int J Pharm; 2022 Jun; 622():121873. PubMed ID: 35640806
[TBL] [Abstract][Full Text] [Related]
23. Using Imiquimod-Induced Psoriasis-Like Skin as a Model to Measure the Skin Penetration of Anti-Psoriatic Drugs.
Lin YK; Yang SH; Chen CC; Kao HC; Fang JY
PLoS One; 2015; 10(9):e0137890. PubMed ID: 26355594
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II.
Babu RJ; Kikwai L; Jaiani LT; Kanikkannan N; Armstrong CA; Ansel JC; Singh M
Pharm Res; 2004 Jan; 21(1):108-13. PubMed ID: 14984264
[TBL] [Abstract][Full Text] [Related]
25. Nanoemulsion loaded gel for topical co-delivery of clobitasol propionate and calcipotriol in psoriasis.
Kaur A; Katiyar SS; Kushwah V; Jain S
Nanomedicine; 2017 May; 13(4):1473-1482. PubMed ID: 28259803
[TBL] [Abstract][Full Text] [Related]
26. Anti-inflammatory effects of alpha-melanocyte-stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor.
Nishida T; Miyata S; Itoh Y; Mizuki N; Ohgami K; Shiratori K; Ilieva IB; Ohno S; Taylor AW
Int Immunopharmacol; 2004 Aug; 4(8):1059-66. PubMed ID: 15222980
[TBL] [Abstract][Full Text] [Related]
27. Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model.
Nagle A; Goyal AK; Kesarla R; Murthy RR
J Liposome Res; 2011 Jun; 21(2):134-40. PubMed ID: 20557280
[TBL] [Abstract][Full Text] [Related]
28. Delivery and Anti-Psoriatic Effect of Silibinin-Loaded Polymeric Micelles: An Experimental Study in the Psoriatic Skin Model.
Chavoshy F; Zadeh BSM; Tamaddon AM; Anbardar MH
Curr Drug Deliv; 2020; 17(9):787-798. PubMed ID: 32703129
[TBL] [Abstract][Full Text] [Related]
29. Co-Delivery of Imiquimod and Curcumin by Nanoemugel for Improved Topical Delivery and Reduced Psoriasis-Like Skin Lesions.
Algahtani MS; Ahmad MZ; Nourein IH; Ahmad J
Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32605030
[TBL] [Abstract][Full Text] [Related]
30. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
Puri R; Jain S
Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
[TBL] [Abstract][Full Text] [Related]
31. Histamine released from epidermal keratinocytes plays a role in α-melanocyte-stimulating hormone-induced itching in mice.
Shimizu K; Andoh T; Yoshihisa Y; Shimizu T
Am J Pathol; 2015 Nov; 185(11):3003-10. PubMed ID: 26358220
[TBL] [Abstract][Full Text] [Related]
32. CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin.
Zhang Y; Xia Q; Li Y; He Z; Li Z; Guo T; Wu Z; Feng N
Theranostics; 2019; 9(1):48-64. PubMed ID: 30662553
[No Abstract] [Full Text] [Related]
33. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis.
Agrawal Y; Petkar KC; Sawant KK
Int J Pharm; 2010 Nov; 401(1-2):93-102. PubMed ID: 20858539
[TBL] [Abstract][Full Text] [Related]
34. Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia).
Ali J; Akhtar N; Sultana Y; Baboota S; Ahuja A
Methods Find Exp Clin Pharmacol; 2008 May; 30(4):277-85. PubMed ID: 18773122
[TBL] [Abstract][Full Text] [Related]
35. Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles.
Sun L; Liu Z; Lin Z; Cun D; Tong HH; Yan R; Wang R; Zheng Y
Int J Nanomedicine; 2018; 13():5625-5635. PubMed ID: 30271151
[TBL] [Abstract][Full Text] [Related]
36. Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis.
Schaper K; Dickhaut J; Japtok L; Kietzmann M; Mischke R; Kleuser B; Bäumer W
J Dermatol Sci; 2013 Jul; 71(1):29-36. PubMed ID: 23643308
[TBL] [Abstract][Full Text] [Related]
37. Transdermal baicalin delivery using diethylene glycol monoethyl ether-mediated cubic phase gel.
Zhang Y; Zhang K; Guo T; Li Y; Zhu C; Feng N
Int J Pharm; 2015 Feb; 479(1):219-26. PubMed ID: 25543112
[TBL] [Abstract][Full Text] [Related]
38. Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation.
Bachhav YG; Patravale VB
Acta Pharm; 2010 Jun; 60(2):153-63. PubMed ID: 21134852
[TBL] [Abstract][Full Text] [Related]
39. Preparation, characterization and pharmacological evaluation of tolterodine hydrogels for the treatment of overactive bladder.
Sun F; Sui C; Zhou Y; Liu X; Shi Y; Wu Y; Li Y
Int J Pharm; 2013 Sep; 454(1):532-8. PubMed ID: 23891744
[TBL] [Abstract][Full Text] [Related]
40. Development of flavanone and its derivatives as topical agents against psoriasis: The prediction of therapeutic efficiency through skin permeation evaluation and cell-based assay.
Alalaiwe A; Lin CF; Hsiao CY; Chen EL; Lin CY; Lien WC; Fang JY
Int J Pharm; 2020 May; 581():119256. PubMed ID: 32220586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
